Sarcoma, Clear Cell clinical trials
The registry lists 31 studies for Sarcoma, Clear Cell across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-28.
Status
- Completed
- 13
- Recruiting
- 7
- Active, not recruiting
- 5
- Status unknown
- 3
- Terminated
- 2
- Enrolling by invitation
- 1
Phase
- Phase 2
- 19
- Phase 1
- 13
- Phase 3
- 1
Where
- United States
- 23
- Canada
- 4
- Netherlands
- 3
- United Kingdom
- 3
- China
- 2
- Poland
- 2
Who runs them
National Cancer Institute (NCI) (4) · Salarius Pharmaceuticals, LLC (2) · Emory University (2) · Children's Oncology Group (2) · Seattle Children's Hospital (2) · St. Jude Children's Research Hospital (2) · Giselle Sholler (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Studies
Recruiting first, then most recently updated. Showing 31 of 31 — search for more.
- NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)RecruitingNCT06239272Phase 1/21 country
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsRecruitingNCT06625190Phase 1/21 country
- B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)RecruitingNCT04897321Phase 11 country
- Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma GroupRecruitingNCT03967834Not applicable1 country
- A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaRecruitingNCT06942442Phase 21 country
- Vebreltinib for Advanced or Metastatic CCSRecruitingNCT07153887Phase 21 country
- A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)Enrolling by invitationNCT05266196Phase 1/21 country
- Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft TissueRecruitingNCT05963035Not applicable1 country
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsActive, not recruitingNCT02867592Phase 21 country
- Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaActive, not recruitingNCT04458922Phase 22 countries
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryCompletedNCT02180867Phase 2/33 countries
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 11 country
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 11 country
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicable2 countries
- QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell SarcomaTerminatedNCT03132155Phase 21 country
- Study on TSR-042 in Advanced Clear Cell SarcomaTerminatedNCT04274023Phase 21 country
- CREATE: Cross-tumoral Phase 2 With CrizotinibCompletedNCT01524926Phase 210 countries
- Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related SarcomasActive, not recruitingNCT03600649Phase 11 country
- To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft TissueCompletedNCT04593758Phase 1/21 country
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 12 countries
- Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV MelanomaCompletedNCT00258687Phase 11 country
- Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasStatus unknownNCT03989596Phase 21 country
- Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab TherapyStatus unknownNCT02968303Phase 21 country
- Aflac ST0901 CHOANOME - Sirolimus in Solid TumorsCompletedNCT01331135Phase 11 country
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 11 country
- Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1/21 country
- Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryCompletedNCT01553539Phase 21 country
- Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsCompletedNCT00335556Phase 25 countries
- Biomarkers in Tissue Samples From Patients With High-Risk Wilms TumorCompletedNCT011180781 country
- Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyStatus unknownNCT00025103Phase 22 countries
- Phase 2 Study in Patients With MiT TumorsCompletedNCT00557609Phase 23 countries